The primary objective of our centre is to translate recent huge advances in the basic understanding of the pathogenesis of coeliac disease to the clinic – to improve disease diagnostics, to implement novel treatments and to identify new therapeutic targets for this common disease.
The secondary objective is to become a clinical research site at the international forefront which will provide optimal patient care and which will be a unique training site for basic scientists and clinicians.
Asbjørn Christophersen and co-authors win price at Oslo University Hospital best paper 2019 award
Nov. 28, 2019 11:23 AM
The paper "Distinct phenotype of CD4 + T cells driving celiac disease identified in multiple autoimmune conditions" published in Nature Medicine earlier this year recieved a price as one of six awarded excellent research paper from OUS in the second half of 2019.
Identification of narrow T-cell phenotype in coeliac disease
May 13, 2019 4:06 PM
Post.doc Asbjørn Christophersen has spear-headed the work that lead to identification of a narrow phenotype of gluten specific CD4+ T cells. This cell subset is also present in other autoimmune conditions and could be a target for future disease therapy.
- Vacant positions Feb. 21, 2019 8:54 AM
Medisinbloggen: What is really gluten?
Dec. 20, 2018 11:14 PM
Gluten is a protein we have enjoyed for thousands of years. But if you have celiac disease, your body thinks that this protein is something dangerous. But what is gluten really?
- B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2 Nov. 16, 2019 10:00 AM
- Update 2020: nomenclature and listing of celiac disease-relevant gluten epitopes recognized by CD4<sup>+</sup> T cells Nov. 19, 2019 10:00 AM
- Single-cell TCR sequencing of gut intraepithelial γδ T cells reveals a vast and diverse repertoire in celiac disease Nov. 16, 2019 10:00 AM